"Clofibric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
| Descriptor ID |
D002995
|
| MeSH Number(s) |
D02.241.081.114.968.500.500 D02.355.726.305.500 D02.455.426.559.389.657.654.305.500
|
| Concept/Terms |
Clofibric Acid- Clofibric Acid
- Clofibrinic Acid
- p-Chlorophenoxyisobutyric Acid
- 2-(4-Chlorophenoxy)-2-methylpropionic Acid
|
Below are MeSH descriptors whose meaning is more general than "Clofibric Acid".
Below are MeSH descriptors whose meaning is more specific than "Clofibric Acid".
This graph shows the total number of publications written about "Clofibric Acid" by people in this website by year, and whether "Clofibric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clofibric Acid" by people in Profiles.
-
Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice. J Infect. 2004 Nov; 49(4):283-90.
-
Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis. 2003 May; 24(5):975-84.
-
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994 Nov; 11(5):301-9.